IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances
Go back to IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 11.29 -0.61 (5.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.90 | 52 Week High | $2.18 | |||
| Open | $11.75 | 52 Week Low | $0.30 | |||
| Day High | $11.75 | P/E | N/A | |||
| Day Low | $11.20 | EPS | $-3.32 | |||
| Volume | 415,334 | |||||
